Application of HSP27 in aspect for improving post-ischemic cardiac systolic function
The technology of a drug or drug candidate, applied in the field of biotechnology or medicine, can solve problems affecting cell contraction function, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0162] Example 1 Expression of HSP27 in ischemia / reperfusion cardiomyocytes
[0163] In this embodiment, the expression of HSP27 in ischemia / reperfusion cardiomyocytes was determined by Western Blot test.
[0164] See the results of Western Blot figure 1 A and figure 1 B, the results showed that there was no significant difference in the expression of HSP27 total protein at 20 minutes of ischemia, 3 minutes and 30 minutes of reperfusion compared with the equilibrium period, but the expression of phosphorylated protein was significantly increased (P<0.01).
Embodiment 2
[0166] Overexpression of wild-type hsp27 gene can improve the contractility of cardiomyocytes after ischemia / reperfusion
[0167] In order to determine whether HSP27 is related to myocardial contraction, the inventors first detected its effect on contractile function at the level of cardiomyocytes.
[0168] The carriers used in the experiment were divided into the following three groups:
[0169] (1) Transfection of cardiomyocytes with control empty vector AdGFP (i.e. control group (CON));
[0170] (2) AdHSP27wt vector expressing wild-type hsp27 gene; and
[0171] (3) AdHSP27mt vector expressing mutant hsp27 gene.
[0172] The results showed that during the 30-minute reperfusion period after 20 minutes of simulated ischemia, the cell contraction amplitude of the AdGFP group was significantly lower than that before ischemia, while the cell contraction amplitude of the AdHSP27wt group was significantly stronger than that of the control group at the late stage of reperfusion g...
Embodiment 3
[0175] Example 3 Effect of HSP27 on TnI and TnT Degradation Caused by Ischemia / Reperfusion
[0176] In search of the target of HSP27 on myofilament, the inventors found that ischemia / reperfusion injury can cause the degradation of cardiomyocyte TnI and TnT.
[0177] The results of Western Blot showed that in the cells transfected with AdHSP27wt group, the degradation of TnI and TnT was significantly lower than that in the control group (P image 3 ).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com